PALB2 and breast carcinoma: Current research on biomarkers for breast cancer including tumor protein 53 (TP53), Survivin, Partner and Localizer of BRCA2 (PALB2), and protein tyrosine phosphatase receptor T (PTPRT) have shown promising avenues for identifying and treating breast cancer [53].